8-aminoquinoline has been researched along with Black Fever in 22 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (13.64) | 18.7374 |
| 1990's | 1 (4.55) | 18.2507 |
| 2000's | 14 (63.64) | 29.6817 |
| 2010's | 4 (18.18) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mesquita, JT; Reimão, JQ; Tempone, AG | 1 |
| Castanys, S; Castanys-Muñoz, E; Gamarro, F; Pérez-Victoria, JM | 1 |
| Al-Banna, M; Buckley, R; Dixon, SA; Miller, AK; Mohamed, K; Sinha, PK; Sundar, S | 1 |
| Cojean, S; Loiseau, PM; Schrével, J | 1 |
| Gomes, MS; Gomes, P; Matos, J; Moreira, R; Tomás, A; Vale, N; Vale-Costa, S | 1 |
| Boelaert, M; Bryceson, AD; Croft, SL; Desjeux, P; Guerin, PJ; Olliaro, P; Sundar, S; Wasunna, MK | 1 |
| Kinoti, D; Kipmutai, R; Kirigi, G; Lodenyo, H; Mbui, J; Mutuma, G; Nyakundi, P; Rashid, R; Wasunna, M | 1 |
| Dwivedi, S; Koirala, S; Rijal, S; Sangraula, H; Sharma, KK | 1 |
| Desjeux, P | 1 |
| Albert, MJ; Felton, JM; Horton, J; Kinoti, D; Kirigi, G; Lodenyo, H; Mbui, J; Rashid, JR; Sabin, AJ; Wasunna, MK | 1 |
| Felton, JM; Horton, J; Jha, TK; Sabin, AJ; Sundar, S; Thakur, CP | 1 |
| Pandey, HP; Singh, RK; Sundar, S | 1 |
| Dueñas-Romero, AM; Loiseau, PM; Saint-Pierre-Chazalet, M | 1 |
| Bories, C; Cojean, S; Huteau, F; Loiseau, PM | 1 |
| Ager, AL; Bartlett, MS; Croft, SL; Khan, IA; McChesney, JD; Nanayakkara, NP; Walker, LA; Yardley, V | 1 |
| Blumbergs, P; Dagli, D; Khan, MS; LaMontagne, MP | 1 |
| Gachihi, GS; Kasili, SK; Mbugua, JM; Mugo, M; Muigai, RK; Rashid, JR; Sherwood, JA; Skillman, DR; Wasunna, KM; Were, JB | 1 |
| Sherwood, JA | 1 |
| Sundar, S | 1 |
| Berman, J; Brewer, T; Carvalho, SF; Dietze, R; Grogl, M; Milhous, W; Sanchez, J; Schuster, B; Valli, LC | 1 |
| Chapman, WL; Hanson, WL; White, MR | 1 |
| Croft, SL; Neal, RA; Nelson, DJ | 1 |
5 review(s) available for 8-aminoquinoline and Black Fever
| Article | Year |
|---|---|
Sitamaquine as a putative antileishmanial drug candidate: from the mechanism of action to the risk of drug resistance.
Topics: Administration, Oral; Aminoquinolines; Animals; Antiprotozoal Agents; Biological Availability; Disease Models, Animal; Drug Resistance; Humans; Leishmania; Leishmaniasis, Visceral | 2011 |
Visceral leishmaniasis: current status of control, diagnosis, and treatment, and a proposed research and development agenda.
Topics: Aminoquinolines; Animals; Antiprotozoal Agents; Asia, Western; Brazil; Developing Countries; Dogs; Female; Humans; Leishmaniasis, Visceral; Male; Paromomycin; Phosphorylcholine; Sudan | 2002 |
Orally effective drugs for kala-azar (visceral leishmaniasis): focus on miltefosine and sitamaquine.
Topics: Administration, Oral; Aminoquinolines; Animals; Antiprotozoal Agents; Clinical Trials as Topic; Dose-Response Relationship, Drug; Humans; India; Leishmania donovani; Leishmaniasis, Cutaneous; Leishmaniasis, Visceral; Phosphorylcholine | 2003 |
A phase II dose-ranging study of sitamaquine for the treatment of visceral leishmaniasis in India.
Topics: Administration, Oral; Adolescent; Adult; Aminoquinolines; Antiprotozoal Agents; Child; Drug Administration Schedule; Female; Humans; India; Leishmaniasis, Visceral; Male; Middle Aged; Treatment Outcome | 2005 |
Visceral leishmaniasis (kala-azar): challenges ahead.
Topics: Aminoquinolines; Amphotericin B; Animals; Antimony; Antiprotozoal Agents; Drug Resistance; Enzyme-Linked Immunosorbent Assay; Humans; India; Leishmania; Leishmaniasis, Visceral; Lipids; Paromomycin; Public Health; Sensitivity and Specificity | 2006 |
5 trial(s) available for 8-aminoquinoline and Black Fever
| Article | Year |
|---|---|
Pharmacokinetics of oral sitamaquine taken with or without food and safety and efficacy for treatment of visceral leishmaniais: a randomized study in Bihar, India.
Topics: Administration, Oral; Adolescent; Adult; Aminoquinolines; Amphotericin B; Antiprotozoal Agents; Area Under Curve; Cohort Studies; Cross-Over Studies; Fasting; Female; Food; Food-Drug Interactions; Half-Life; Humans; India; Leishmaniasis, Visceral; Male; Middle Aged; Prospective Studies; Young Adult | 2011 |
A phase II dose-increasing study of sitamaquine for the treatment of visceral leishmaniasis in Kenya.
Topics: Adolescent; Adult; Aged; Aminoquinolines; Animals; Antiprotozoal Agents; Child; Child, Preschool; Cohort Studies; Dose-Response Relationship, Drug; Female; Humans; Kenya; Leishmania donovani; Leishmaniasis, Visceral; Male; Middle Aged; Treatment Outcome | 2005 |
A phase II dose-ranging study of sitamaquine for the treatment of visceral leishmaniasis in India.
Topics: Administration, Oral; Adolescent; Adult; Aminoquinolines; Antiprotozoal Agents; Child; Drug Administration Schedule; Female; Humans; India; Leishmaniasis, Visceral; Male; Middle Aged; Treatment Outcome | 2005 |
Phase 2 efficacy trial of an oral 8-aminoquinoline (WR6026) for treatment of visceral leishmaniasis.
Topics: Administration, Oral; Adolescent; Adult; Aminoquinolines; Animals; Antiprotozoal Agents; Body Weight; Capsules; Child; Female; Humans; Leishmania donovani; Leishmaniasis, Visceral; Male; Spleen | 1994 |
Phase 2 trial of WR6026, an orally administered 8-aminoquinoline, in the treatment of visceral leishmaniasis caused by Leishmania chagasi.
Topics: Administration, Oral; Adolescent; Adult; Aminoquinolines; Animals; Antiprotozoal Agents; Child; Dose-Response Relationship, Drug; Female; Humans; Kidney Diseases; Leishmania; Leishmaniasis, Visceral; Male; Middle Aged; Treatment Outcome | 2001 |
13 other study(ies) available for 8-aminoquinoline and Black Fever
| Article | Year |
|---|---|
Combination therapy with nitazoxanide and amphotericin B, Glucantime®, miltefosine and sitamaquine against Leishmania (Leishmania) infantum intracellular amastigotes.
Topics: Aminoquinolines; Amphotericin B; Animals; Antiprotozoal Agents; Drug Combinations; Leishmania infantum; Leishmaniasis, Visceral; Macrophages, Peritoneal; Meglumine; Meglumine Antimoniate; Mice; Nitro Compounds; Organometallic Compounds; Parasitic Sensitivity Tests; Phosphorylcholine; Thiazoles | 2014 |
Characterization of an ABCG-like transporter from the protozoan parasite Leishmania with a role in drug resistance and transbilayer lipid movement.
Topics: Aminoquinolines; Animals; Antiprotozoal Agents; ATP-Binding Cassette Transporters; Base Sequence; Biological Transport, Active; Chloroquine; DNA, Protozoan; Drug Resistance; Fluorescent Dyes; Genes, Protozoan; Humans; Leishmania infantum; Leishmaniasis, Visceral; Lipid Bilayers; Phosphorylcholine; Protozoan Proteins; Recombinant Proteins; Transformation, Genetic | 2008 |
Peptidomimetic and organometallic derivatives of primaquine active against Leishmania infantum.
Topics: Aminoquinolines; Animals; Antiprotozoal Agents; Cell Culture Techniques; Cell Survival; Inhibitory Concentration 50; Leishmania infantum; Leishmaniasis, Visceral; Macrophages; Mice; Mice, Inbred BALB C; Organometallic Compounds; Parasitic Sensitivity Tests; Peptidomimetics; Phosphorylcholine; Primaquine | 2012 |
Visceral leishmaniasis with concomittant post kala-azar dermal leishmaniasis responds to oral sitamaquine: case report.
Topics: Administration, Oral; Adolescent; Aminoquinolines; Animals; Antiprotozoal Agents; Female; Humans; Leishmaniasis, Cutaneous; Leishmaniasis, Visceral | 2003 |
[Therapeutic options for visceral leishmaniasis].
Topics: Aminoquinolines; Amphotericin B; Antiprotozoal Agents; Humans; Leishmaniasis, Visceral; Paromomycin | 2005 |
Interaction of sitamaquine with membrane lipids of Leishmania donovani promastigotes.
Topics: Air; Aminoquinolines; Animals; Antiprotozoal Agents; Cell Membrane; Drug Interactions; Leishmania donovani; Leishmaniasis, Visceral; Membrane Lipids; Phospholipids; Static Electricity; Sterols; Water | 2007 |
Selection and phenotype characterisation of sitamaquine-resistant promastigotes of Leishmania donovani.
Topics: Aminoquinolines; Animals; Antiprotozoal Agents; Culture Media; Drug Resistance; Leishmania donovani; Leishmaniasis, Visceral; Macrophages; Mice; Mice, Inbred BALB C; Phenotype | 2008 |
Antiparasitic activities and toxicities of individual enantiomers of the 8-aminoquinoline 8-[(4-amino-1-methylbutyl)amino]-6-methoxy-4-methyl-5-[3,4-dichlorophenoxy]quinoline succinate.
Topics: Aminoquinolines; Animals; Antifungal Agents; Antiprotozoal Agents; Dogs; Female; Hemolysis; Humans; Leishmania donovani; Leishmaniasis, Visceral; Malaria; Male; Methemoglobinemia; Mice; Mice, Inbred BALB C; Plasmodium berghei; Pneumocystis carinii; Pneumonia, Pneumocystis; Stereoisomerism; Structure-Activity Relationship | 2008 |
Analogues of 8-[[6-(diethylamino) hexyl]amino]-6-methoxy-4-methylquinoline as candidate antileishmanial agents.
Topics: Aminoquinolines; Animals; Antiprotozoal Agents; Cricetinae; Leishmaniasis, Visceral; Mesocricetus; Structure-Activity Relationship | 1980 |
Miltefosine for visceral leishmaniasis.
Topics: Administration, Oral; Aminoquinolines; Antiprotozoal Agents; Drug Synergism; Humans; Leishmaniasis, Visceral; Phosphorylcholine | 2000 |
Drug resistance in Indian visceral leishmaniasis.
Topics: Aminoquinolines; Amphotericin B; Antimony; Antiprotozoal Agents; Dose-Response Relationship, Drug; Drug Resistance; Geography; History, 20th Century; History, 21st Century; Humans; India; Leishmaniasis, Visceral; Paromomycin; Pentamidine; Phosphorylcholine; Treatment Outcome | 2001 |
Chemotherapy of experimental visceral leishmaniasis in the opossum.
Topics: Aminoquinolines; Animals; Antiprotozoal Agents; Body Weight; Female; Leishmaniasis, Visceral; Liver; Male; Meglumine; Meglumine Antimoniate; Opossums; Organ Size; Organometallic Compounds; Sorbitol; Spleen | 1989 |
Anti-leishmanial effect of allopurinol ribonucleoside and the related compounds, allopurinol, thiopurinol, thiopurinol ribonucleoside, and of formycin B, sinefungin and the lepidine WR6026.
Topics: Adenosine; Allopurinol; Aminoquinolines; Animals; Antiprotozoal Agents; Cricetinae; Female; Formycins; Leishmania; Leishmaniasis; Leishmaniasis, Visceral; Macrophages; Mice; Mice, Inbred Strains; Ribonucleosides; Thionucleosides | 1985 |